Cardiac Disease Prevalence Fuels Growth In The Peripheral Arterial Disease Market: Transformative Forces Shaping the Peripheral Arterial Disease Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Will the Peripheral Arterial Disease Industry Market Size Be by 2025?
In recent times, there has been substantial growth in the market size of peripheral arterial disease. The market is predicted to expand from $4.36 billion in 2024 to $4.76 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.2%. The notable growth experienced in the past era can be linked to the innovation of medical equipment, gene therapy and regenerative medicine, pharmacogenomics, as well as digital health and remote monitoring.

What's the Long-Term Growth Forecast for the Peripheral Arterial Disease Market Size Through 2029?
The market size for peripheral arterial disease is predicted to experience substantial growth in the upcoming years, reaching a value of $6.62 billion in 2029 with an 8.6% compound annual growth rate (CAGR). Factors contributing to this growth during the forecast period include collaborative care teams, the use of minimally invasive procedures, and lifestyle and exercise prescriptions. The key trends projected for the forecast period are vascular tele-rehabilitation, multimodal pain management, advances in wound care, and widespread public health campaigns.

View the full report here:
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

What Are the Key Growth Drivers Fueling the Peripheral Arterial Disease Market Expansion?
The peripheral arterial disease market is experiencing growth, propelled by the increasing rate of cardiac diseases. These diseases often affect the primary blood vessels that fuel the heart muscle. Through the enhancement of blood flow, symptom alleviation, reduction of cardiovascular risk, and improvement of life quality, peripheral arterial disease treatments are proving to be beneficial for cardiac patients. As an illustration, reports by The Australian Bureau of Statistics (ABS), a government agency in Australia, stated in December 2023 that in the year 2022, one person out of every twenty (approximately 1.3 million people or 5.2%) was affected by stroke, heart, or vascular diseases. Additionally, the American College of Cardiology, a non-profit medical association located in the United States, projected in April 2022 that the risk factors for ischemic heart disease could rise by 30.7% to 29 million by 2025. The increasing rate of cardiac diseases, therefore, is the force behind the growth of the peripheral arterial disease market. Peripheral Arterial Disease Market Driver: Increasing Occurrence Of Diabetes Is Projected To Boost The Peripheral Arterial Diseases

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

What Are the Key Trends Driving Peripheral Arterial Disease Market Growth?
Significant corporations running the peripheral arterial disease market are channeling their efforts into creating cutting-edge medical tools like the intravascular lithotripsy (IVL) catheter. The goal is to increase the effectiveness of treatments, foster better patient results and cut down convalescence periods for those living with vascular diseases. The IVL catheter, a medical instrument, is effective in managing calcified arterial obstructions by administering measured shockwaves which decompose the calcium. This greatly advances blood circulation and boosts the flexibility of vessels during procedures like angioplasty. Take, for example, in September 2024, Shockwave Medical, Inc., an American medical tech company, rolled out the Shockwave E8 peripheral IVL catheter. This device is crafted to treat peripheral arterial disease through targeted intravascular lithotripsy, where sound waves are used to fragment calcium formations in arterial walls. This novel technique aids in restoring blood circulation while keeping trauma to nearby tissues at a minimum. The complex design of the catheter makes manoeuvring through intricate vascular structures easier, thus making it versatile for an entire gamut of patients.

How Is the Peripheral Arterial Disease Market Segmented?
The peripheral arterial disease market covered in this report is segmented -

1) By Treatment Type: Devices, Catheters, Drugs, Other Types
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By End User: Hospitals, Specialty Clinics, Others End-Users

Subsegments:
1) By Devices: Stents, Balloons, Atherectomy Devices
2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires
3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators
4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12999&type=smp

Which Companies Are Leading the Charge in Peripheral Arterial Disease Market Innovation?
Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.

Which Regions Are Leading the Global Peripheral Arterial Disease Market in Revenue?
North America was the largest region in the peripheral artery disease market in 2024. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12999

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.